Get started
Author

Heather Hughes

Observed names: H Hughes, H. Hughes, Heather Y Hughes, Heather Y. Hughes, Heather Yaun Hughes
Observed institutions: Prisma Health, Centers for Disease Control and Prevention, National Institutes of Health, Mayo Clinic, University College London Hospitals NHS Foundation Trust, Medical University of South Carolina, Royal Free London NHS Foundation Trust, University of Dundee, Augusta University, Charlie Norwood VA Medical Center, Leighton Hospital, Good Samaritan University Hospital, Greenville Memorial Hospital, Acucela (United States), National Center for Emerging and Zoonotic Infectious Diseases, Ralph H. Johnson VA Medical Center, National Institute of Allergy and Infectious Diseases, National Maternity Hospital, MRC Unit for Lifelong Health and Ageing, University College London, Medical Research Council
ORCID: 0000-0002-9733-3172
Observed ORCID: 0000-0002-9733-3172
OpenAlex ID: A5103096985
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel
2021 · Justin S. Lee, Jason M. Goldstein, et al. · PLoS ONE · 110
PDF
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial
2019 · Stuart A Taylor, Sue Mallett, et al. · The Lancet Respiratory Medicine · 67
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Missed opportunities for diabetes prevention: post-pregnancy follow-up of women with gestational diabetes mellitus in England
2011 · Mary Pierce, Jo Modder, et al. · British Journal of General Practice · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Detection and Whole-Genome Sequencing of Carbapenemase-Producing Aeromonas hydrophila Isolates from Routine Perirectal Surveillance Culture
2016 · Heather Y. Hughes, Sean P. Conlan, et al. · Journal of Clinical Microbiology · 37
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Postexposure prophylaxis after hepatitis C occupational exposure in the interferon-free era
2016 · Heather Y. Hughes, David K. Henderson · Current Opinion in Infectious Diseases · 21
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Prenatal findings and associated survival rates in fetal ventriculomegaly: A prospective observational study
2022 · Gillian A. Ryan, Alexander O. Start, et al. · International Journal of Gynecology & Obstetrics · 13
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12
PDF
Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation
2020 · Allison Ross Eckard, Heather Y. Hughes, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 12
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11
PDF
Severe fetal ventriculomegaly: Fetal morbidity and mortality, caesarean delivery rates and obstetrical challenges in a large prospective cohort
2021 · Alex O. Start, Gillian A. Ryan, et al. · Prenatal Diagnosis · 11
Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
2019 · Margaret Morrison, Heather Y. Hughes, et al. · Digestive Diseases and Sciences · 11
Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6
2020 · Allison Ross Eckard, Heather Y. Hughes, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 8
A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization
2019 · Heather Y. Hughes, Robin T. Odom, et al. · Infection Control and Hospital Epidemiology · 8
Diagnostic complication and molecular characteristics of Hb SC-Chicago disease with α-thal-2 (-α3.7 deletion): effects of multiple variant on patient’s phenotype
2009 · Heather Yaun Hughes, Kathleen McKie, et al. · Annals of Hematology · 6
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Works count: 48
Citation count: 2,660
H-index: 15
I10-index: 21
Year
Topic
Type